Impact of Epithelial-Mesenchymal Transition on the Immune Landscape in Breast Cancer.Khadri FZ, Issac MSM, Gaboury LACancers (Basel) 2021-10-12;13(20).

Severe Inflammatory Reactions in Mice Expressing a GFI1^P2A Mutant Defective in Binding to the Histone Demethylase KDM1A (LSD1).Fraszczak J, Arman KM, Lacroix M, Vadnais C, Gaboury L, Möröy TJ Immunol 2021-09-15;207(6):1599-1615.

The RanBP2/RanGAP1-SUMO complex gates β-arrestin2 nuclear entry to regulate the Mdm2-p53 signaling axis.Blondel-Tepaz E, Leverve M, Sokrat B, Paradis JS, Kosic M, Saha K, Auffray C, Lima-Fernandes E, Zamborlini A, Poupon A, Gaboury L, Findlay J, Baillie GS, Enslen H, Bouvier M, Angers S, Marullo S, Scott MGHOncogene 2021-03-01;40(12):2243-2257.

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC.Gauvin C, Krishnan V, Kaci I, Tran-Thanh D, Bédard K, Albadine R, Leduc C, Gaboury L, Blais N, Tehfe M, Routy B, Florescu MCurr Oncol 2021-01-20;28(1):593-605.

IFN-λ Enhances Constitutive Expression of MHC Class I Molecules on Thymic Epithelial Cells.Benhammadi M, Mathé J, Dumont-Lagacé M, Kobayashi KS, Gaboury L, Brochu S, Perreault CJ. Immunol. 2020-09-01;205(5):1268-1280.

Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer.Aubert L, Nandagopal N, Steinhart Z, Lavoie G, Nourreddine S, Berman J, Saba-El-Leil MK, Papadopoli D, Lin S, Hart T, Macleod G, Topisirovic I, Gaboury L, Fahrni CJ, Schramek D, Meloche S, Angers S, Roux PPNat Commun 2020-07-24;11(1):3701.

Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts.Dieudé M, Turgeon J, Karakeussian Rimbaud A, Beillevaire D, Qi S, Patey N, Gaboury LA, Boilard E, Hébert MJAm. J. Transplant. 2020-03-20;20(3):726-738.

Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.Morency D, Dumitra S, Parvez E, Martel K, Basik M, Robidoux A, Poirier B, Holloway CMB, Gaboury L, Sideris L, Meterissian S, Boileau JFAnn. Surg. Oncol. 2019-11-20;26(13):4337-4345.

MCM2, MCM4, and MCM6 in Breast Cancer: Clinical Utility in Diagnosis and Prognosis.Issac MSM, Yousef E, Tahir MR, Gaboury LANeoplasia 2019-08-30;21(10):1015-1035.

Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer.El-Khoury V, Béland M, Schritz A, Kim SY, Nazarov PV, Gaboury L, Sertamo K, Bernardin F, Batutu R, Antunes L, Bennett CW, Faÿs F, Berchem G, Kim YJBr. J. Cancer 2018-08-01;119(5):580-590.